Logo LMU Klinikum
  • Startseite
  • Einrichtungen
  • Kontakt
  • Presse
  • International Patient Office
Ukraine-Hilfe Notfall
  • Medizin & Pflege
    • Einrichtungen
      • Kliniken
      • Abteilungen
      • Institute
      • Zentren
      • Post-Covid Ambulanz
      Bereiche
      • Pflege
      • Krankenhaushygiene
      • Qualitätsmanagement
      • Apotheke
      • Transplantationsbeauftragte
  • Patienten & Besucher
      • Patienten
      • Besucher
      • Service und Unterstützung
      • Anfahrt und Parken
      • Wichtige Dokumente
  • Forschung
  • Lehre
  • Das Klinikum
      • Wir über uns
      • Zentrale Bereiche
      • Historie
      • Standorte
      • Publikationen
      • Amtliche Veröffentlichungen
  • Karriere
      • Stellenanzeigen
      • Berufsgruppen
      • Benefits
      • Berufsausbildung
      • Freiwilligendienste
      • LMU Health Academy
  • Aktuelles
      • Newsmeldungen 
      • Veranstaltungen
      • Pressemitteilungen
Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie
Urheberschaft ungeklärt
Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie
Urheberschaft ungeklärt
Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie
Urheberschaft ungeklärt
Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie
Urheberschaft ungeklärt
  1. Startseite LMU Klinikum
  2. Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie
  3. Forschung und Lehre
  4. Literaturverzeichnis und Publikationen
  • Immunhämatologie und Blutdepot
    • Anforderungsformulare und Dokumente der Transfusionsmedizin
       
      • Gebrauchs- und Fachinformationen
         
        • Gesetzliche Bestimmungen
           
          • Kontakt Transfusionsmedizin/ Immunhämatologie
             
          • Hämostaseologie und Gerinnungsambulanz
            • Blutungsneigung
               
              • Thromboseneigung
                 
                • Hämophiliezentrum
                   
                  • Kontakt zur Hämostaseologie und Gerinnungsambulanz
                     
                  • Labor für Immungenetik und molekulare Diagnostik (LfIMD)
                    • Anforderungsformulare LfIMD
                       
                      • Leistungsspektrum des LfIMD
                         
                        • Weiterführende Links
                           
                          • Kontakt zum LfIMD
                             
                          • Thrombozytenspende 
                            • Blutspenden
                               
                              • Verwendung der Blutspenden
                                 
                                • Allgemeines 
                                   
                                  • Gesetzliche Regelungen
                                     
                                    • Eignung zur Thrombozytenspende
                                       
                                      • Spenderaustestung
                                         
                                        • Spendepausen
                                           
                                          • Ausschlusskriterien
                                             
                                            • Unterlagen für die Spende
                                               
                                              • Kontakt Thrombozytenspende 
                                                 
                                              • Zelltherapeutika
                                                • Anforderungsformulare
                                                   
                                                  • Gebrauchs- und Fachinformation Zelltherapeutika
                                                     
                                                    • Weitere Dokumente
                                                       
                                                      • Kontakt Zelltherapeutika
                                                         
                                                      • Forschung und Lehre
                                                        • Forschungsgruppen
                                                          • AG Wichmann
                                                             
                                                            • AG Kellner
                                                               
                                                            • Studentenunterricht/ PJ-Seminare
                                                               
                                                              • Literaturverzeichnis und Publikationen
                                                                 
                                                                • Kontakt zu Forschung & Lehre der ATMZH
                                                                   
                                                                • Linkliste der ATMZH
                                                                   
                                                                  • Kontakt
                                                                    • Anfahrtsbeschreibung und Lageplan
                                                                       

                                                                    Literaturverzeichnis und Publikationen

                                                                    Hier können Sie Einblicke und Eindrücke in die Veröffentlichungen unserer Mediziner und Wissenschaftler gewinnen und sich über unser Wirken in den letzten 5 Jahren weiter Informieren.

                                                                    2024
                                                                    • Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes
                                                                    • Preoperative Midazolam and Patient-Centered Outcomes of Older Patients: The I-PROMOTE Randomized Clinical Trial
                                                                    • Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy
                                                                    • Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated anti-tumor efficacy of tafasitamab
                                                                    • Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade
                                                                    • Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets
                                                                    2023
                                                                    • Purified recombinant lentiviral Vpx proteins maintain their SAMHD1 degradation efficiency in resting CD4+ T cells
                                                                    • Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes
                                                                    • Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
                                                                    • The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials
                                                                    • Predictive value of molecular matching tools for the development of donor specific HLA-antibodies in patients undergoing lung transplantation
                                                                    • Monitoring Blood Supply in Germany: A Regulatory Perspective
                                                                    • Principles of Therapeutic Apheresis in Neurological Disease
                                                                    • Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group
                                                                    • Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study
                                                                    • [Basics for the Use of Andexanet]
                                                                    • Predictive value of molecular matching tools for the development of donor specific HLA-antibodies in patients undergoing lung transplantation
                                                                    • Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
                                                                    • Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
                                                                    2022
                                                                    • Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages
                                                                    • Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
                                                                    • ATMPs: New Challenge for Transfusion Services
                                                                    • Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses
                                                                    • Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes
                                                                    • Understanding opalescence measurements of biologics - A comparison study of methods, standards, and molecules
                                                                    • [Autoimmune haemolytic anemias]
                                                                    • Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation
                                                                    • Receiving, Handling, Storage, Thawing, Distribution, and Administration of CAR-T Cells Shipped from the Manufacturing Facility
                                                                    • Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
                                                                    • Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
                                                                    • Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer
                                                                    • The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo
                                                                    • Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
                                                                    • HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients
                                                                    • Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection
                                                                    • Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study
                                                                    • Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years
                                                                    • [Update of the Surviving Sepsis Campaign guidelines 2021-What is new?]
                                                                    • [Practice of pharmaceutical thrombosis prophylaxis and anticoagulation in patients with sepsis and pre-existing anticoagulation or heparin-induced type II thrombocytopenia-Results of a nationwide survey in German intensive care units]
                                                                    • A novel approach to laboratory assessment and reporting of platelet von Willebrand factor
                                                                    • [SEPSIS-3.0-Is intensive care medicine ready for ICD-11?]
                                                                    • [Erratum to: Treatment of sepsis-induced coagulopathy. Results of a Germany-wide survey in intensive care units]
                                                                    • [Anticoagulation in intensive care medicine]
                                                                    • Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
                                                                    • Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
                                                                    2021
                                                                    • Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
                                                                    • Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective
                                                                    • SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
                                                                    • Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
                                                                    • [Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]
                                                                    • Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia
                                                                    • The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
                                                                    • Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
                                                                    • Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo
                                                                    • Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients
                                                                    • [Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units]
                                                                    • Persistent inhibitor in acquired haemophilia A: A case for emicizumab?
                                                                    2020
                                                                    • Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation
                                                                    • Epigenetic Compound Screening Uncovers Small Molecules for Reactivation of Latent HIV-1
                                                                    • Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
                                                                    • The global scale, distribution and growth of aviation: Implications for climate change
                                                                    • [COVID-19 from the Perspective of Haematology and Haemostaseology]
                                                                    • Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation
                                                                    • ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells
                                                                    • Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial
                                                                    • Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
                                                                    • Comparison of Two Different Fibrinogen Concentrates in an in vitro Model of Dilutional Coagulopathy
                                                                    2019
                                                                    • Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke
                                                                    • Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry
                                                                    • Data mining of reference intervals for coagulation screening tests in adult patients
                                                                    • Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia
                                                                    • Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy
                                                                    • Cellular Therapeutics - Living Drugs: A Rising Star at the Horizon of Immunotherapy in Hematology and Oncology
                                                                    • Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia
                                                                    • Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion
                                                                    • Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
                                                                    • Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy
                                                                    • Perioperative Management of a Patient with Severe Factor V Deficiency Presenting with Chronic Subdural Hematoma: A Clinical Report
                                                                    • Emicizumab in the Treatment of Acquired Haemophilia: A Case Report
                                                                    Zurück zur Startseite

                                                                    50 Jahre Campus Großhadern - Tag der offenen Tür

                                                                    Am Samstag, 14. September 2024, präsentiert sich die LMU Medizin von 10 bis 16 Uhr beim Tag der Offenen Tür am Campus Großhadern mit einem vielfältigen Programm für die gesamte Familie: mit Vorträgen, Führungen, Infoständen und Mitmach-Aktionen. Dazu gibt es ein buntes und spannendes Rahmenprogramm mit Aktivitäten für Kinder, Foodtrucks und Musik.

                                                                    mehr Informationen

                                                                    Abteilung für Transfusionsmedizin, Zell-therapeutika und Hämostaseologie

                                                                    Marchioninistraße 15, 81377 München

                                                                    siehe Kontakt des gewünschten Bereichs oben
                                                                    +49 (0) 89 4400-78896
                                                                    FKOLZ RiopibgYplgbvim-fulrvfiuyziu-mi
                                                                    • Impressum
                                                                    • Datenschutz

                                                                    • Zurück zur Startseite der ATMZH
                                                                    • Anfahrt und Parken am Klinikum der Universität München
                                                                    Anmeldung für Redakteure
                                                                  • Startseite
                                                                  • Einrichtungen
                                                                  • Kontakt
                                                                  • Presse
                                                                  • International Patient Office

                                                                    Abteilung fü...

                                                                    • Immunhämatologie und Blutdepot
                                                                      • Anforderungsformulare und Dokumente der Transfusionsmedizin
                                                                      • Gebrauchs- und Fachinformationen
                                                                      • Gesetzliche Bestimmungen
                                                                      • Kontakt Transfusionsmedizin/ Immunhämatologie
                                                                    • Hämostaseologie und Gerinnungsambulanz
                                                                      • Blutungsneigung
                                                                      • Thromboseneigung
                                                                      • Hämophiliezentrum
                                                                      • Kontakt zur Hämostaseologie und Gerinnungsambulanz
                                                                    • Labor für Immungenetik und molekulare Diagnostik (LfIMD)
                                                                      • Anforderungsformulare LfIMD
                                                                      • Leistungsspektrum des LfIMD
                                                                      • Weiterführende Links
                                                                      • Kontakt zum LfIMD
                                                                    • Thrombozytenspende 
                                                                      • Blutspenden
                                                                      • Verwendung der Blutspenden
                                                                      • Allgemeines 
                                                                      • Gesetzliche Regelungen
                                                                      • Eignung zur Thrombozytenspende
                                                                      • Spenderaustestung
                                                                      • Spendepausen
                                                                      • Ausschlusskriterien
                                                                      • Unterlagen für die Spende
                                                                      • Kontakt Thrombozytenspende 
                                                                    • Zelltherapeutika
                                                                      • Anforderungsformulare
                                                                      • Gebrauchs- und Fachinformation Zelltherapeutika
                                                                      • Weitere Dokumente
                                                                      • Kontakt Zelltherapeutika
                                                                    • Forschung und Lehre
                                                                      • Forschungsgruppen
                                                                        • AG Wichmann
                                                                        • AG Kellner
                                                                      • Studentenunterricht/ PJ-Seminare
                                                                      • Literaturverzeichnis und Publikationen
                                                                      • Kontakt zu Forschung & Lehre der ATMZH
                                                                    • Linkliste der ATMZH
                                                                    • Kontakt
                                                                      • Anfahrtsbeschreibung und Lageplan